Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released May 8, 2014, after the close
10-Q filed May 8, 2014, 38 days after period end · 0000320017-14-000022
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2013 | Q1 2012 | Q1 2011 | Q1 2010 |
|---|---|---|---|---|
| Revenue | $4.06K | — | $3.77M | $19.59M |
| Net Income | -$13.68K | -$8.80K | -$9.35M | -$10.17M |
| EPS Diluted | -$0.49 |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.53 |
| -$0.08 |
| -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
